Can plant-based compounds fight brain tumours? Researchers find Amaryllidaceae extracts kill glioblastoma cells by cutting off their energy supply.
End of Content.
Get the latest creative news from us about politics, business, sport and travel
End of Content.
Dr Sylvester Ifeanyi Omoruyi is a Senior Lecturer in the Department of Anatomical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand. He holds a PhD in Medical Bioscience from the University of the Western Cape, an MSc and BSc (Hons) in Anatomy from the University of Benin, and an MPhil in Cancer Science from Stellenbosch University. His research focuses on drug discovery and therapeutic targets for non-communicable diseases, particularly brain tumours and neurodegenerative disorders. He investigates bioactive natural products synthetic compounds to identify neuroprotective and anticancer agents, with the goal of advancing affordable therapeutic strategies.

Dr Sylvester Ifeanyi Omoruyi is a Senior Lecturer in the Department of Anatomical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand. He holds a PhD in Medical Bioscience from the University of the Western Cape, an MSc and BSc (Hons) in Anatomy from the University of Benin, and an MPhil in Cancer Science from Stellenbosch University. His research focuses on drug discovery and therapeutic targets for non-communicable diseases, particularly brain tumours and neurodegenerative disorders. He investigates bioactive natural products synthetic compounds to identify neuroprotective and anticancer agents, with the goal of advancing affordable therapeutic strategies.
Can plant-based compounds fight brain tumours? Researchers find Amaryllidaceae extracts kill glioblastoma cells by cutting off their energy supply.